0001104659-23-081674.txt : 20230717 0001104659-23-081674.hdr.sgml : 20230717 20230717170307 ACCESSION NUMBER: 0001104659-23-081674 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230713 FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox Jennifer A. CENTRAL INDEX KEY: 0001841557 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41740 FILM NUMBER: 231092249 MAIL ADDRESS: STREET 1: C/O NUVATION BIO INC. STREET 2: 1500 BROADWAY, SUITE 1401 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apogee Therapeutics, Inc. CENTRAL INDEX KEY: 0001974640 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 880588063 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 221 CRESCENT ST. STREET 2: BUILDING 17, SUITE 102B CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 650-394-5230 MAIL ADDRESS: STREET 1: 221 CRESCENT ST. STREET 2: BUILDING 17, SUITE 102B CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Apogee Therapeutics, LLC DATE OF NAME CHANGE: 20230420 3/A 1 tm2321456-5_3aseq1.xml OWNERSHIP DOCUMENT X0206 3/A 2023-07-13 2023-07-13 0 0001974640 Apogee Therapeutics, Inc. APGE 0001841557 Fox Jennifer A. C/O APOGEE THERAPEUTICS, INC. 221 CRESCENT ST., BLDG. 17, STE. 102B. WALTHAM MA 02453 1 0 0 0 Common Stock 34824 D Consists of 34,824 shares of restricted common stock, one quarter of which will vest on May 26, 2024, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer. This amendment is being filed to correct the number of shares reported in Table I due to a calculation error. /s/ Jane Pritchett Henderson, as attorney-in-fact for Jennifer Fox 2023-07-17